Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Windtree Therapeutics

Recent news which mentions Windtree Therapeutics

Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
Tickers WINT
Tags Market News WINT General
From Benzinga
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
Tickers NEWS WINT
Tags Biotech Windtree Therapeutics Benzinga
From Benzinga
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
Tickers NEWS WINT
Tags General Partner Content WINT
From Benzinga
Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
Tickers NEWS WINT
Tags Partner Content WINT Market News
From Benzinga
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
Tickers WINT
Tags General Partner Content WINT
From Benzinga
Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
Tickers WINT
Tags Market News WINT Partner Content
From Benzinga
How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators
Tickers WINT
Tags General Market News Partner Content
From Benzinga
Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
Tickers WINT
Tags General WINT Partner Content
From Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
Tickers AZN BMY MLYS NVS
Tags Penny Stocks WINT Market News
From Benzinga
Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis
Tickers WINT
Tags Interview Penny Stocks Windtree Therapeutics
From Benzinga
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
Tickers BMY NVS WINT
Tags Penny Stocks WINT NVS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.